Apollo Endosurgery Inc Quick Ratio (APEN) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Apollo Endosurgery inc   (NASDAQ: APEN)

Apollo Endosurgery Inc 's Quick Ratio

APEN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 1.44 below Apollo Endosurgery Inc average.

Within Medical Equipment & Supplies industry 118 other companies have achieved higher Quick Ratio than Apollo Endosurgery Inc in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 931 to 1838.

Explain Quick Ratio?
How much Cash & cash equivalents APEN´s has?
What are APEN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APEN Quick Ratio (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4
Y / Y Current Liabilities Change 172.93 % 14.02 % 30.13 % 19.57 % -23.87 %
Y / Y Cash & cash equivalent Change -37.15 % 119.07 % 135.69 % 125.56 % 142.29 %
Quick Ratio MRQ 1.44 4.06 4.56 5.86 6.26
APEN's Total Ranking # 1838 # 931 # 822 # 692 # 658
Seq. Current Liabilities Change 140 % 0.51 % 17.47 % -3.69 % 0.26 %
Seq. Cash & cash equivalent Change -14.8 % -10.48 % -8.56 % -9.88 % 196.95 %



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 119
Healthcare Sector # 774
Overall Market # 1838


Quick Ratio Statistics
High Average Low
8.23 2.9 0.21
(Dec 31 2015)   (Jun 30 2017)




Financial Statements
Apollo Endosurgery Inc 's Current Liabilities $ 40 Millions Visit APEN's Balance sheet
Apollo Endosurgery Inc 's Cash & cash equivalent $ 57 Millions Visit APEN's Balance sheet
Source of APEN's Sales Visit APEN's Sales by Geography


Cumulative Apollo Endosurgery Inc 's Quick Ratio

APEN's Quick Ratio for the trailling 12 Months

APEN Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 62.32 % 6.17 % -5.04 % -45.85 % -62.95 %
Y / Y Cash & cash equivalent TTM Growth 48.21 % 131.07 % 123.09 % 102.35 % 72.54 %
Quick Ratio TTM 3.25 5.12 4.68 4.23 3.56
Total Ranking TTM # 4510 # 4423 # 794 # 4452 # 768
Seq. Current Liabilities TTM Growth 40.86 % 3.42 % 6.84 % 4.29 % -7.87 %
Seq. Cash & cash equivalent TTM Growth -10.73 % 13.1 % 18.33 % 24.05 % 39.19 %

Quick ratio ranking by company, industry and sector >> Back to APEN Financial Strength Comparisons >> Go to Compare APEN Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2022 to $39.54 millions, cumulative Quick Ratio decreased to 3.25 above the APEN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 239 other companies have achieved higher Quick Ratio than Apollo Endosurgery Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4423 to 4510.

Explain Quick Ratio?
How much Cash & cash equivalents APEN´s has?
What are APEN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 240
Healthcare Sector # 1161
Within the Market # 4510


trailing twelve months Quick Ratio Statistics
High Average Low
5.12 1.98 0.73
(Sep 30 2022)   (Mar 31 2018)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Medical Equipment & Supplies Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Nuwellis Inc   3.90 $ 18.306  Millions$ 4.688  Millions
Orthopediatrics Corp  3.83 $ 118.290  Millions$ 30.871  Millions
Dror Ortho-Design, Inc.  3.83 $ 1.039  Millions$ 0.271  Millions
Brainsway Ltd   3.77 $ 47.581  Millions$ 12.632  Millions
Pulmonx Corporation  3.76 $ 102.051  Millions$ 27.115  Millions
Soleno Therapeutics Inc  3.71 $ 14.602  Millions$ 3.936  Millions
American Oncology Network Inc   3.61 $ 26.926  Millions$ 7.466  Millions
Neuroone Medical Technologies Corp  3.60 $ 11.141  Millions$ 3.099  Millions
Cardiovascular Systems Inc   3.59 $ 132.002  Millions$ 36.761  Millions
Nexalin Technology Inc   3.59 $ 6.994  Millions$ 1.949  Millions
Nuo Therapeutics Inc   3.42 $ 2.051  Millions$ 0.600  Millions
Innovage Holding Corp   3.39 $ 184.429  Millions$ 54.355  Millions
Tela Bio Inc   3.39 $ 42.019  Millions$ 12.403  Millions
Tenon Medical Inc   3.39 $ 8.570  Millions$ 2.530  Millions
Apyx Medical Corp  3.33 $ 10.192  Millions$ 3.060  Millions
Nephros Inc   3.32 $ 3.634  Millions$ 1.096  Millions
Sensus Healthcare Inc   3.32 $ 25.520  Millions$ 7.697  Millions
Lemaitre Vascular Inc   3.19 $ 82.691  Millions$ 25.941  Millions
Icecure Medical Ltd  3.18 $ 24.251  Millions$ 7.624  Millions
Edwards Lifesciences Corporation  3.13 $ 4,245.400  Millions$ 1,354.300  Millions
Edap Tms Sa  3.11 $ 70.712  Millions$ 22.750  Millions
Motus Gi Holdings Inc   2.93 $ 14.042  Millions$ 4.799  Millions
Irhythm Holdings Inc   2.92 $ 213.144  Millions$ 73.014  Millions
Logicmark Inc  2.89 $ 6.977  Millions$ 2.414  Millions
Nutriband Inc   2.77 $ 1.985  Millions$ 0.717  Millions
Inogen Inc   2.72 $ 187.014  Millions$ 68.648  Millions
Staar Surgical Co  2.69 $ 211.639  Millions$ 78.612  Millions
Treace Medical Concepts Inc   2.69 $ 81.252  Millions$ 30.245  Millions
Lucid Diagnostics Inc   2.67 $ 22.474  Millions$ 8.425  Millions
Milestone Scientific Inc   2.64 $ 8.715  Millions$ 3.300  Millions

Date modified: 2026-09-08T15:10:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.